id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-299375-ve4lag21	Yang, Yichang	Use of herbal drugs to treat COVID-19 should be with caution	2020-05-15		.txt	text/plain	928	55	48	On April 14, 2020, a Chinese official announced at a press conference that indications of three patent herbal drugs were approved to be expanded to include COVID-19 symptoms. 2,3 Certain batches of an injectable herbal drug called Xiyanping, which is recommended by the Chinese Diagnosis and Treatment Protocol of COVID-19, 4 have already been recalled after reports of adverse effects. 5 Although these patent herbal drugs have been used clinically for several years, when we apply them to a novel disease like COVID-19, especially in combination with other antivirals, antibiotics, and immune suppressants, the safety should be cautiously evaluated. Driven by the claim that some patent herbal drugs can effectively treat COVID-19, some patients with flu symptoms who fear quarantine measures are likely to selfmedicate with herbal remedies and avoid going to hospital, thus delaying the proper diagnosis and treatment of the disease, and hampering the government's testing, tracing, and quarantining efforts.	./cache/cord-299375-ve4lag21.txt	./txt/cord-299375-ve4lag21.txt